Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice

Journal of Molecular Neuroscience

Volumn 18, Issue 1-2, 2002, Pages 151-165

  Holmes, Andrew ^a   Yang, Rebecca J ^a   Crawley, Jacqueline N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Anxiety; Chlordiazepoxide; Elevated plus maze; Galanin; Light dark exploration test; Multitiered strategy; Norepinephrine; Stress; Transgenic mice; Yohimbine

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BENZODIAZEPINE RECEPTOR; CHLORDIAZEPOXIDE; GALANIN; NEUROPEPTIDE; NORADRENALIN; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY NEUROSIS; CONFERENCE PAPER; CONTROLLED STUDY; EMOTION; EXPLORATORY BEHAVIOR; FEMALE; GENE OVEREXPRESSION; LOCOMOTION; LOCUS CERULEUS; MALE; MAZE TEST; MEASUREMENT; MOTOR COORDINATION; MOUSE; NONHUMAN; PHENOTYPE; RAT; SENSORY SYSTEM; SOCIAL BEHAVIOR; STRESS; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY; TRANSGENIC MOUSE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; CHLORDIAZEPOXIDE; EXPLORATORY BEHAVIOR; FEMALE; GALANIN; GENOTYPE; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; NOREPINEPHRINE; PHENOTYPE; RECEPTORS, ADRENERGIC, ALPHA-2; UP-REGULATION; YOHIMBINE;

ANIMALIA; MUS MUSCULUS;

EID: 0036200155     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:18:1-2:151     Document Type: Conference Paper

References (116)

1. The contribution of the amygdala to normal and abnormal emotional states
2. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration
3. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
4. Mice deficient for both corticotropin-releasing factor receptor 1 (CRFR1) and CRFR2 have an impaired stress response and display sexually dichotomous anxiety-like behavior
5. Galanin and galanin antagonists: Molecular and biochemical perspectives
6. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex
7. Flumazenil induces benzodiazepine partial agonist-like effects in BALB/c but not C57BL/6 mice
8. Galanin immunoreactivity within the primate basal forebrain: Evolutionary change between monkeys and apes
9. Anxiolytic-like action of centrally administered galanin
10. Mice over-expressing galanin have elevated heat nociceptive threshold
11. Galanin microinjected into the medial preoptic nucleus facilitates female- and male-typical sexual behaviors in the female rat
12. Gonadal steroid-dependent GAL-IR cells within the medial preoptic nucleus (MPN) and the stimulatory effects of GAL within the MPN on sexual behaviors
13. A confocal microscopic analysis of galaninergic hyperinnervation of cholinergic basal forebrain neurons in Alzheimer's disease
14. Galanin receptor subtypes
15. Molecular biology and pharmacology of galanin receptors
16. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies
17. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies
18. Evaluation of circulating galanin levels after exercise-induced pituitary hormone secretion in man
19. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: A hypothesis for the role of galaninin accentuating cholinergic dysfunction in dementia
20. Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease
21. Distribution of galanin messenger RNA-expressing cells in murine brain and their regulation by leptin in regions of the hypothalamus
22. Anxiolytic-like effects of yohimbine in the murine plus-maze: Strain independence and evidence against alpha 2-adrenoceptor mediation
23. Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus
24. Understanding corticotropin releasing factor neurobiology: Contributions from mutant mice
25. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: An in situ hybridization study
26. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat
27. Genetics of mouse behavior: Interactions with laboratory environment
28. Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines
29. Behavioral phenotyping of transgenic and knockout mice: Experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests
30. The role of galanin in feeding behavior
31. Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus
32. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
33. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice
34. Galanin receptor antagonists M40 and C7 block galanin-induced feeding
35. Neurobiology of fear responses: The role of the amygdala
36. Human galanin reduces plasma norepinephrine levels in man
37. Galanin/alpha2-adrenoceptor interactions in telencephalic and diencephalic regions of the rat
38. Galanin and NH2-terminal galanin fragments in central cardiovascular regulation
39. The importance of the pattern of stimulation in relation to the response of automatic effectors
40. Cloning, pharmacological characterization and distribution of a novel galanin receptor
41. Differential regulation of tyrosine hydroxylase, neuropeptide Y and galanin gene expression in the pons and medulla oblong at a following chronic oral administration of 2% saline: A combined in situ hybridisation and immunohistochemical study
42. Distribution of galanin-like immunoreactivity in the human brain
43. Galanin-like immunoreactivity within amygdaloid and hypothalamic neurons that project to the midbrain central grey in rat
44. Is there a future for neuropeptide receptor ligands in the treatment of anxiety disorders?
45. Distribution of a rat galanin receptor mRNA in rat brain
46. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery
47. A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain
48. Neurobiology and clinical aspects of neuropeptide Y
49. Review of the validity and variability of the elevated plus-maze as an animal model of anxiety
50. Coexistence of peptides with classical transmitters
51. Galanin: Basic research discoveries and therapeutic implications
52. Galanin in ascending systems. Focus on coex-istence with 5-hydroxytryptamine and noradrenaline
53. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus
54. Targeted gene mutation approaches to the study of anxiety-like behavior in mice
55. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus
56. Coexisting neurotransmitters in central noradrenergic neurons
57. Dopamine D5 receptor null mutant mice show attenuated behavioral responses to a dopamine agonist
58. Behavioral profile of wild mice in the elevated plus-maze test for anxiety
59. Responses of Swiss-Webster mice to repeated plus-maze experience: Further evidence for a qualitative shift in emotional state?
60. Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze
61. Prior test experience abolishes the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test
62. Galanin and galanin receptors
63. Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury
64. Interactive effects of acute stress and yohimbine on anxiety as measured with the elevated plus-maze
65. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2
66. Stress and colchicine do not induce the release of galanin from the external zone of the median eminence
67. The effects on feeding of galanin and M40 when injected into the nucleus of the solitary tract, the lateral parabrachial nucleus, and the third ventricle
68. Corticotropin-releasing factor, norepinephrine, and stress
69. Galanin: Stimulation of feeding induced by medial hypothalamic injection of this novel peptide
70. Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: A microdialysis study
71. Fear and the brain: Where have we been, and where are we going?
72. Co-storage of peptides and classical transmitters in neurons
73. Decreased type 2 corticotropin-releasing hormone receptor mRNA expression in the ventromedial hypothalamus during repeated immobilization stress
74. Characterization of benzodiazepine-sensitive behaviors in the A/J and C57BL/6J inbred strains of mice
75. Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats
76. Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus
77. Modulation of hippocampal excitability and seizures by galanin
78. Galanin inhibits performance on rodent memory tasks
79. Distribution of galanin-like immunoreactivity in the rat central nervous system
80. 125I-galanin binding sites in the rat central nervous system
81. GALR1 galanin receptor mRNA is co-expressed by galanin neurons but not cholinergic neurons in the rat basal forebrain
82. Anxiogenic-like action of galanin after intra-amygdala administration in the rat
83. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential
84. The galanin receptor antagonist M40 blocks the central cardiovascular actions of the galanin N-terminal fragment (1-15)
85. (188) Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex
86. Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training
87. Distribution of galaninergic immunoreactivity in the brain of the mouse
88. Galanin induces a hyperpolarization of norepinephrine-containing locus coeruleus neurons in the brainstem slice
89. Cardiovascular actions of galanin
90. A galanin-like peptide in the central nervous system and intestine of the rat
91. Galanin decreases the activity of locus coeruleus neurons in vitro
92. Galanin receptors inhibit the spontaneous firing of locus coeruleus neurones and interact with mu-opioid receptors
93. Participation of endogenous galanin in the suppression of baroreceptor reflex response by locus coeruleus in the rat
94. The modified light ↔ dark transition test in mice: Evaluation of classic and putative anxiolytic and anxiogenic drugs
95. 125I-galanin binding sites in the rat central nervous system
96. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
97. Brain noradrenergic responses to footshock after chronic activity-wheel running
98. Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease
99. Overproduction of corticotropin-releasing factor in transgenic mice: A genetic model of anxiogenic behavior
100. Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats
101. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
102. Alpha2-adrenoceptor-mediated restraint of norepinephrine synthesis, release, and turnover during immobilization in rats
103. Neuropeptide Y and galanin in norepinephrine release in hypothalamic slices
104. Neuropeptide Y and galanin enhance the inhibitory effects of clonidine on norepinephrine release from medulla oblongata of rats
105. Modulation of norepinephrine release by galanin in rat medulla oblongata
106. Cholecystokinin in anxiety
107. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice
108. Galanin: A significant role in depression?
109. The effects of intrathecal galanin and C-fiber stimulation on the flexor reflex in the rat
110. Intrathecal galanin potentiates the spinal analgesic effect of morphine: Electrophysiological and behavioural studies
111. Pharmacological evidence supporting a role for galanin in cognition and affect
112. Galanin and spinal nociceptive mechanisms: Recent advances and therapeutic implications
113. Galanin/GMAP-and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors
114. Galanin-5-hydroxytryptamine interactions: Electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors